Home » Topics » Regulatory

Regulatory
RSS

FDA approves Duzallo to treat hyperuricemia associated with gout

Aug. 22, 2017

FDA approves Vyxeos for two types of AML

Aug. 4, 2017

FDA grants approval to ibrutinib for adult patients with chronic GvHD

Aug. 3, 2017

FDA approves Idhifa for R/R AML with IDH2 mutation

Aug. 2, 2017

European Commission approves AbbVie's Maviret for chronic HCV genotypes 1-6

July 31, 2017

European Commission approves Dompe's cenegermin eye drops for neurotrophic keratitis

July 21, 2017

FDA approves Vosevi for re-treatment of chronic HCV infection

July 19, 2017

FDA approves Nerlynx as extended adjuvant therapy for early stage HER2-positive breast cancer

July 18, 2017

FDA approves Tremfya for moderate to severe plaque psoriasis

July 14, 2017

Korea first to approve Invossa-K cell and gene therapy for degenerative arthritis

July 13, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...